Cerebral Therapeutics Names Julie Foster as Chief Operating Officer
Cerebral Therapeutics, Inc., a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today the appointment of MedTech industry veteran Julie Foster as Chief Operating Officer.
- Cerebral Therapeutics, Inc., a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today the appointment of MedTech industry veteran Julie Foster as Chief Operating Officer.
- Julie succeeds John Foster who served as Cerebral Therapeutic’s President and COO since 2019, who will move into a business advisor role for the company.
- Julie Foster is a seasoned leader with over 30 years of experience at Medtronic.
- As the new COO, Julie Foster will lead and scale the company’s growth and business operations, reporting to Dan Abrams, M.D., Chief Executive Officer of Cerebral Therapeutics.